PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1564079
PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1564079
Cancer Gene Therapy
Global Cancer Gene Therapy Market to Reach US$8.8 Billion by 2030
The global market for Cancer Gene Therapy estimated at US$2.3 Billion in the year 2023, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 21.1% over the analysis period 2023-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.9% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Gene Transfer Therapy segment is estimated at 15.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$615.4 Million While China is Forecast to Grow at 20.0% CAGR
The Cancer Gene Therapy market in the U.S. is estimated at US$615.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 20.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.0% and 17.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.0% CAGR.
Global Cancer Gene Therapy Market - Key Trends and Drivers Summarized
Why Is Cancer Gene Therapy Revolutionizing Cancer Treatment?
Cancer gene therapy represents a groundbreaking approach in the fight against cancer, offering innovative solutions by targeting the genetic root causes of cancer rather than just treating the symptoms. Unlike traditional treatments like chemotherapy and radiation, which attack both healthy and cancerous cells, gene therapy aims to alter or repair the genes that cause cancer to develop and spread. This method provides a more precise and potentially less harmful alternative. Techniques such as gene editing, using CRISPR technology, or delivering therapeutic genes via viral vectors, allow doctors to replace mutated genes, introduce new genes that help fight cancer, or make cancer cells more recognizable to the immune system. The impact of cancer gene therapy extends beyond treatment, as it offers long-term remission and, in some cases, even a cure. The ability to manipulate the genetic foundation of cancer represents a monumental shift in how we approach treatment, transforming cancer care from a one-size-fits-all model to a more personalized and effective strategy.
How Are Technological Advances Shaping Cancer Gene Therapy?
Technological innovation is the driving force behind the rapid advancements in cancer gene therapy. The most significant development in recent years is the rise of CRISPR-Cas9, a gene-editing technology that allows scientists to precisely modify genes within cancer cells. This tool has revolutionized the field, enabling researchers to either correct mutations or knock out genes that contribute to cancer progression. Viral vectors, which deliver therapeutic genes directly into cancer cells, are also becoming more efficient and safer, thanks to innovations in vector engineering. These vectors are crucial in gene therapy as they provide a way to transport genetic material into cells without causing harm to the patient. Additionally, next-generation sequencing (NGS) is advancing cancer gene therapy by offering deeper insights into the genetic mutations driving individual cancers. This technology allows for highly personalized treatments based on the specific genetic profile of a patient’s cancer. Artificial intelligence and machine learning are also playing pivotal roles by analyzing large datasets and predicting the outcomes of gene therapy interventions, making it easier to design effective treatments. These technological advances have not only made gene therapy more accessible but have also improved its safety and efficacy, driving its growth in the oncology field.
What Are the Emerging Trends and Challenges in Cancer Gene Therapy?
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Cancer Gene Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
III. MARKET ANALYSIS
IV. COMPETITION
